Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0356920110600050351
Korean Journal of Anesthesiology
2011 Volume.60 No. 5 p.351 ~ p.356
Kappa-opioid receptor activation during reperfusion limits myocardial infarction via ERK1/2 activation in isolated rat hearts
Kim June-Hong

Jang Young-Ho
Chun Kook-Jin
Kim Jun
Park Yong-Hyun
Kim Jeong-Su
Kim Jin-Mo
Lee Mi-Young
Abstract
Background: We investigated whether p42/p44 extracellular signal-regulated kinases (ERK1/2) and/or phosphatidylinositol-3-OH kinase (PI3K)-Akt play a crucial role in cardioprotection by ¥ê-opioid receptor (KOP) activation.

Methods: Langendorff perfused rat hearts were subjected to 30 min of regional ischemia and 2 h of reperfusion. Antagonists of ERK1/2 and PI3K were perfused in hearts treated with the KOP agonist U50488H (U50). Infarct size was measured after 2 h of reperfusion. The phosphorylation states of ERK1/2 and Akt by Western immunoblots were determined. Drugs were perfused for a period of 5 min before and 30 min after reperfusion.

Results: Inhibition of ERK1/2 (26.8 ¡¾ 2.9%, P < 0.05 vs. U50) but not PI3K (15.5 ¡¾ 1.1%, P > 0.05 vs. U50) completely abrogated the anti-infarct effect of U50488H. Western blot analysis revealed a significant increase in ERK1/2 but not Akt phsophorylation in U50488H-treated hearts as compared to control hearts when measured immediately after reperfusion.

Conclusions: KOP activation effectively reduces myocardial infarction. The anti-infarct effect of U50488H is mediated by the ERK1/2, but not the PI3K-Akt pathway.
KEYWORD
Coronary occlusion, Heart, Myocardial function, Opioid receptors, Reperfusion
FullTexts / Linksout information
Listed journal information
MEDLINE ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø